Renata Gallagher
Clinical Genetics (M.D.) · San Francisco, CANPI 1699880856
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Amryt Pharma Holdings Ltd at 54.2% of the total. Reporting peaked in 2022 at $5,750 and has fallen 93.9% since, to $350 in 2025.
Across 11 payments — averaging $670.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amryt Pharma Holdings Ltd$4K
- Sanofi$3K
- UCB, Inc.$143
- Orchard Therapeutics North America$117
- Pfizer$90
- Ultragenyx Pharmaceutical Inc.$30
Across 77 payments — averaging $17,545 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$465K
- Mallinckrodt Hospital Products Inc.$331K
- Mallinckrodt Enterprises LLC$309K
- Ultragenyx Pharmaceutical Inc.$246K
- Sanofi US Services Inc.$166
What the payments were for
- Consulting fees$4,00054%
- Speaking & faculty fees$3,00041%
- Food & beverage$3505%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amryt Pharma Holdings Ltd | 1 | $4,000 |
| Sanofi | 6 | $3,000 |
| UCB, Inc. | 1 | $143 |
| Orchard Therapeutics North America | 1 | $117 |
| Pfizer | 1 | $90 |
| Ultragenyx Pharmaceutical Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,380 in reported general payments places this provider in the 80th percentile of 91 clinical genetics (m.d.) providers in California.
Other clinical genetics (m.d.) in San Francisco
- Jose CamachoSan Francisco$126K
- Irene ChangSan Francisco$10K
- David BlairSan Francisco$1K
- James GoldbergSan Francisco$1K
- Hind Al SaifSan Francisco$237
- Joyce SoSan Francisco$165
- Randeep BrarSan Francisco$133
- Nicola LongoLos Angeles$295K
- John GargusOrange$124K
- John CroninWoodside$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.